Abstract
Maternal care provides a vital framework for protecting women’s cervical health across preconception, antenatal, and postpartum periods. Pregnancy induces profound hormonal, structural, and immunological changes in the cervix such as increased vascularity, softening, and reactive cellular alterations that may heighten susceptibility to infections like human papillomavirus (HPV) and complicate cytological interpretation. Integrating cervical screening within maternal healthcare presents an important opportunity for early detection and prevention of cervical disease. While Pap smears and colposcopy are generally safe during pregnancy, physiological changes may cause false-positive or indeterminate results, prompting most guidelines to defer routine screening until postpartum unless clinically indicated. Low-grade lesions often regress after delivery, whereas high-grade cervical intraepithelial neoplasia (CIN 2/3) and invasive cancer require careful multidisciplinary management balancing maternal and fetal outcomes. Key challenges include limited awareness, inadequate provider training, and inconsistent postpartum follow-up. Incorporating cervical screening into antenatal protocols, strengthening healthcare worker capacity, and promoting counselling and surveillance for high-risk women can enhance preventive outcomes. Maternal care thus represents a strategic platform for integrating cervical cancer prevention, fostering early intervention, and reducing global cervical disease burden through coordinated education, screening, and follow-up efforts.

Key Words: Maternal care, Cervical health, Pregnancy, HPV, Screening, Cytology, Cervical cancer prevention.
Citation:Chowdhury I (2025) Current Maternal Awareness, Knowledge, and Practices on Cervical Cancer Prevention. Journal of Cancer Cervix Eradication. 9(1):28-33